期刊文献+

人子宫颈组织中端粒酶人端粒酶RNA组分基因表达和人端粒酶蛋白基因编码催化蛋白亚基mRNA的相关性分析 被引量:2

The expression of hTR gene and its correlation with hTERT mRNA in human uterine cervical tissues
下载PDF
导出
摘要 目的探讨端粒酶、人端粒酶RNA组分(hTR)基因表达、分布及其与人端粒酶蛋白基因编码催化蛋白亚基(hTERT)基因表达的关联性。方法对51例宫颈活检组织进行端粒酶hTR、hTERT基因原位杂交检测。结果51例组织中28例hTR原位杂交阳性,32例hTERT阳性,表达随着病变的严重程度而增加。在高度鳞状上皮内病变(HSIL)/宫颈鳞状上皮癌(SCC)和低度鳞状上皮内病变(LSIL)/炎症组间差异有统计学意义,而且hTR和hTERT表达具有相关性(P<0.05)。结论在宫颈病变组织中,检测hTR基因表达情况可用于宫颈癌的早期诊断和鉴别。 Objective To explore the expression and distribution of hTR gene and its relationship with hTERT mRNA expression in human uterine cervical tissues. Methods 51 cervical samples were divided into 4 groups (cervieitis, LSIL, HSIL and SCC) and detected with ISH of hTR and hTERT RNA. Results There were 28 and 32 positive expression respectively in 51 samples, and their expression increasing with cervical lesion severe degrees. The difference is significant between HSIL/SCC and LSIL/Cervieitis groups, and the correlation was also significant with hTR and hTERT gene expression (P〈0.05). Conclusion The detection of hTR mRNA expres- sion may be used to diagnose and differentiate in early cervical carcinoma.
出处 《山西医药杂志(上半月)》 CAS 2009年第12期1081-1083,共3页 Shanxi Medical Journal
基金 深圳市科技计划项目(200204068 200802033)
关键词 人端粒酶RNA 人端粒酶蛋白基因编码催化蛋白亚基 宫颈疾病 原位杂交 human telomerase RNA human telomerase reverse transcriptase Cervix diseases In situ hybridization
  • 相关文献

参考文献9

  • 1Feng J, Funk WD,Wang SS, et al. RNA component of human telomerase. Science, 1995, 269 : 1236-1241.
  • 2Bosh FX, Manos MM, Munoz N,et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst,1995,87:796-802.
  • 3苑昕,张波,应建明,金燕燕,侯琳.端粒酶基因在人肿瘤组织中的表达[J].中华病理学杂志,2000,29(1):16-19. 被引量:37
  • 4Wallace MB, Block M, Hoffman BJ, et al. Detection of telomerase expression in mediastinal lymph nodes of patients with lung cancer. Am J Respir Crit Care Med, 2003,167(12) :1670-1675.
  • 5Wang SZ, Sun JH, Zhang W, et al. Telomerase activity in cervical intraepithellal neoplasia. Chin Med J, 2004, 117(2) :202-206.
  • 6Frost M, Bobak JB, Gtanant R, et al. Localization of telomerase hTERT protein and hTR in benign mucosa, dysplasia, and squamous cell carcinoma of the cervix. Am J Clin Pathol, 2000, 114: 726-734.
  • 7杨邵敏,张波,王俊梅,廖松林,韩继生,卫建平,侯琳.人端粒酶hTERT抗体制备、鉴定及在肿瘤检测中的应用[J].中华病理学杂志,2002,31(1):50-54. 被引量:8
  • 8Cheung ANY, Chiu PM, Tsun KL, et al. Chromosome in situ hybridization, Ki-67, and telomerase immunocytoehemistry in liquid based cervical cytology. J Clin Pathol, 2004, 57 : 721-727.
  • 9宋建明,王一理,司履生.宫颈癌中HPV16E6基因表达与p53蛋白积累[J].中华病理学杂志,1997,26(6):368-368. 被引量:11

二级参考文献15

  • 1张静如.中国共产党与社会现代化[J].北京师范大学学报(社会科学版),1991(3):1-7. 被引量:14
  • 2Burger AM, Bibby MC, Double JA. Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy. Br J Cancer, 1997,75: 516-522.
  • 3Weinrich SL, Pruzan R, Ma L, et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet, 1997, 17:498-502.
  • 4Liu Y, Snow BE, Hande MP, et al. The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr Biol, 2000,10:1459-1462.
  • 5Nakayama J, Tahara H, Tahara E, et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet, 1998, 18: 65-68.
  • 6Koyanagi Y, Kobayashi D, Yajima T, et al. Telomerase activity is down regulated via decreases in hTERT mRNA but not TEP1 mRNA or hTERC during the differentiation of leukemia cells. Anticancer Res,2000, 20, 773-778.
  • 7Erlanger BF. The preparation of antigenic hapten-carrier conjugates: a survey. Methods Enzymol,1980, 70:85-104.
  • 8吴从愿.单克隆抗体的制备、鉴定、提纯、标记和应用.见:王世真,林汉,周前,主编.核医学与核生物学.北京:科学出版社,1990.141-168.
  • 9Ausubel FM, Brent R, Kingston RE, et al. Short protocols in molecular biology, 3rd ed. New York: John Wiley & Sons Press, 1995, 104-105.
  • 10Liddell JE, Cryer A.A practical guide to monoclonal antibodies. West Sussex:John Wiley & Sons,1991.110-115.

共引文献52

同被引文献24

  • 1朱晓应,符伟军,洪宝发,林茂虎.端粒酶启动子调控p53基因表达对T24细胞的影响[J].中华实验外科杂志,2006,23(2):193-194. 被引量:5
  • 2阎炳智,王洁,张波,董福生,侯琳,王旭.p53基因抑制涎腺腺样囊性癌细胞端粒酶及增殖活性[J].中华口腔医学杂志,2006,41(1):45-48. 被引量:7
  • 3Robertson AJ,Anderson JM,Beck JS,et al.Observer variability in histopathological reporting of cervical biopsy specimens.J Clin Pathol,1989,42(3):231-238.
  • 4Ismail SM,Colclough AB,Dinnen JS,et al.Observer variation in histopathological diagnosis and grading of cervical intraepithelial neoplasia.Br Med J,1989,298(6675):707-710.
  • 5Creagh T,Bridger JE,Kupek E,et al.Pathologist variation in reporting cervical borderline epithelial abnormalities and cervical intraepithelial neoplasia.J Clin Pathol,1995,48(1):59-60.
  • 6McCluggage WG,Bharucha H,Caughley LM,et al.Interobserver variation in the reporting of cervical colposcopic biopsy specimens:comparison of grading systems.J Clin Pathol,1996,49(10):833-835.
  • 7Stoler MH,Schiffman M.Interobserver reproducibility of cervical cytologic and histologic interpretations:realistic estimates from the ASCUS-LSIL triage study.JAMA,2001,285(11):1500-1505.
  • 8Cai B,Ronnett BM,Stoler M,et al.Longitudinal evaluation of interobserver and intraobserver agreement of cervical intraepithelial neoplasia diagnosis among an experienced panel of gynecologic pathologists.Am J Surg Pathol,2007,31(12):1854-1860.
  • 9Pinto AP,Schlecht NF,Woo TY,et al.Biomarker (ProEx C,p16(INK4A),and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics.Mod Pathol,2008,21(9):1067-1074.
  • 10Cremer ML,Alonzo TA,Alspach AE,et al.Diagnostic reproducibility of cervical intraepithelial neoplasia 3 and atrophy in menopausal women on hematoxylin and eosin,Ki-67,and p16 stained slides.J Low Genit Tract Dis,2010,14(2):108-112.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部